Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-01-15The Use of Toxin Botulinum A Toxin in Patients With Parkinson's Disease and Multiple System Disease, Affected by Refractory Detrusor Overactivity.
-
CLINICAL_TRIALS study record update · 2009-01-14An Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Relationship Study of L-Dopa/Carbidopa in a Novel Release Formulation in Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2009-01-09A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Multiple Doses of BIIB014 Administered Orally in Subjects With Early Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2009-01-05Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control and Treatment of Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2008-12-31A Randomised Controlled Trial Evaluating the Effect of an Individual Auditory Cueing Device on Freezing and Gait Speed in People With Parkinson's Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-11-13Characterizing Mechanisms of Fronto-Subcortical Dysfunction: A Comparison Between Parkinson's Disease and Obsessive-Compulsive Disorder
-
CLINICAL_TRIALS study record update · 2008-11-07Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 2-Year Study To Evaluate The Effects Of GPI 1485 On [123I]b-CIT/SPECT Scanning And Clinical Efficacy In Symptomatic PD Patients Receiving Dopamine Agonist Therapy.
-
CLINICAL_TRIALS study record update · 2008-10-01A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the Effect of Fipamezole on Neurogenic Orthostatic Hypotension in Patients With Multiple System Atrophy or Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-09-03Efficiency of Physiotherapeutic Care in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-08-20Online Automatic Recognition of Freezing of Gait Episodes
-
CLINICAL_TRIALS study record update · 2008-08-14An Open Label, Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet® CR (Carbidopa/Levodopa) at 4 Daily Dose Levels in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2008-06-12The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Over 3 Months
-
CLINICAL_TRIALS study record update · 2008-05-23Exercise, Physical Function, and Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-05-23Study of Adherence of Stalevo, Entacapone and Levodopa
-
CLINICAL_TRIALS study record update · 2008-05-23European Study of Therapeutic Compliance in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-04-25Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease: a Double-Blind Placebo Controlled Crossover Study
-
CLINICAL_TRIALS study record update · 2008-04-11Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study.
-
CLINICAL_TRIALS study record update · 2008-04-04The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other Men
-
CLINICAL_TRIALS study record update · 2008-03-27Phase I Study of Subthalamic GAD Gene Transfer in Medically Refractory Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2008-03-25A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-MONTH EXTENSION STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF A DOSE RANGE OF SAFINAMIDE OF 50-200 MG/DAY, AS ADD-ON THERAPY IN PATIENTS WITH EARLY IDIOPATHIC PARKINSON'S DISEASE TREATED WITH A STABLE DOSE OF A SINGLE DOPAMINE AGONIST.
-
CLINICAL_TRIALS study record update · 2008-03-04Diagnosis and Natural History Protocol for Patients With Neurological Conditions
-
CLINICAL_TRIALS study record update · 2008-03-04Effect of Antiglutamatergic Treatment in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-03-04Adenosine A2A Blockade With KW-6002 in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-03-04Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2008-03-04Can Stimulation of Frontal Cortical Regions Facilitate Performance on Tests of Procedural Implicit Learning and Analogical Reasoning?